An engineered ligand-responsive Csy4 endoribonuclease controls transgene expression from Sendai virus vectors.

SeV-based vectors with the SrC switch should find wide applications in stem cell research, regenerative medicine, and gene therapy, especially when precise control of reprogramming factor expression is desirable.